AstraZeneca PLC Ordinary Shares · Depreciation & Amortization

Latest reported$6.37Bperiod endingJun 30, 2026

AZN Depreciation & Amortization ($300.91M → $6.37B)

Annual Depreciation & Amortization

High-resolution chart · PNG

AZN depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Depreciation & Amortization — Annual fiscal periods (USD)
Period ending	Depreciation & Amortization (USD)
Dec 31, 2025	5,733,000,000
Dec 31, 2024	5,065,000,000
Dec 31, 2023	4,934,000,000
Dec 31, 2022	5,254,000,000
Dec 31, 2021	4,102,000,000
Dec 31, 2020	2,896,000,000
Dec 31, 2019	3,762,000,000
Dec 31, 2018	3,753,000,000
Dec 31, 2017	3,036,000,000
Dec 31, 2016	2,357,000,000
Dec 31, 2015	2,852,000,000
Dec 31, 2014	3,282,000,000
Dec 31, 2013	4,583,000,000
Dec 31, 2012	2,518,000,000
Dec 31, 2011	2,550,000,000
Dec 31, 2010	2,741,000,000
Dec 31, 2009	2,087,000,000
Dec 31, 2008	2,620,000,000
Dec 31, 2007	1,856,000,000
Dec 31, 2006	1,345,000,000
Dec 31, 2005	1,327,000,000
Dec 31, 2004	1,268,000,000
Dec 31, 2003	1,293,000,000
Dec 31, 2002	960,000,000
Dec 31, 2001	860,000,000
Dec 31, 2000	929,023,778
Dec 31, 1999	1,069,000,000
Dec 31, 1998	821,000,000
Dec 31, 1997	357,072,009
Dec 31, 1996	371,613,521
Dec 31, 1995	299,771,308
Dec 31, 1994	276,722,480
Dec 31, 1993	254,422,815
Dec 31, 1992	242,670,589
Dec 31, 1991	291,905,243
Dec 31, 1990	300,914,316